Drugs and synaptic transmission
Studying this course? Keep your progress in one place.
Key facts
- Drugs can mimic a neurotransmitter, block receptors or channels, change its release or removal, or supply a precursor.
- Nicotine mimics ACh and is not broken down; alpha toxin blocks ACh receptors, causing paralysis.
- Lidocaine blocks voltage-gated sodium channels, so no action potentials form.
- L-DOPA crosses the blood-brain barrier and becomes dopamine in Parkinson's disease.
- MDMA releases serotonin and inhibits its reuptake.
How drugs affect synapses
Drugs mimic, block, boost or supply a neurotransmitter, or block conduction along the axon.
Many drugs and toxins interfere with synaptic transmission or conduction of impulses. An agonist mimics a neurotransmitter and stimulates the receptor; an antagonist blocks it. Others increase the neurotransmitter in the cleft by stimulating release or inhibiting removal, or supply a precursor. You need five examples.
Nicotine
- Mimics acetylcholine
- Stimulates
Alpha toxin
- Blocks acetylcholine receptors
- Paralysis
Lidocaine
- Blocks sodium ion channels in axons
- No impulses
L-DOPA
- Precursor of dopamine
Which drug type would supply a precursor so that more neurotransmitter can be made?
Nicotine and alpha toxin
Both bind to ACh receptors: nicotine opens the channels and stimulates, while alpha toxin blocks them and causes paralysis.
Nicotine has a shape similar to ACh, so it binds ACh receptors, opens sodium ion channels and depolarises the postsynaptic membrane. Acetylcholinesterase does not break it down, so stimulation is prolonged. Alpha toxin in cobra venom blocks the receptors at neuromuscular junctions, so the muscle is not depolarised. Paralysis of the diaphragm and intercostal muscles can cause death from respiratory failure.
| Nicotine | Alpha toxin | |
|---|---|---|
| Binds to ACh receptors | Binds to ACh receptors | Binds to ACh receptors |
| Sodium ion channels | Sodium ion channels open | Sodium ion channels stay closed |
| Postsynaptic membrane | Postsynaptic membrane depolarised | Postsynaptic membrane not depolarised |
| Result | Prolonged stimulation | Paralysis |
Nicotine
- Binds to ACh receptors:
- Binds to ACh receptors
- Sodium ion channels:
- Sodium ion channels open
- Postsynaptic membrane:
- Postsynaptic membrane depolarised
- Result:
- Prolonged stimulation
Alpha toxin
- Binds to ACh receptors:
- Binds to ACh receptors
- Sodium ion channels:
- Sodium ion channels stay closed
- Postsynaptic membrane:
- Postsynaptic membrane not depolarised
- Result:
- Paralysis
Why can alpha toxin cause death?
Lidocaine
Lidocaine blocks voltage-gated sodium channels in sensory axons, so no action potentials form and pain impulses cannot reach the brain.
Lidocaine is a local anaesthetic: it blocks voltage-gated sodium ion channels in the membrane of sensory neurones. The numbness is local because it is injected where needed, and it fades as the drug is removed.
- 1
Channels blocked
voltage-gated sodium ion channels in the axon membrane
- 2
No sodium entry
sodium ions cannot enter the axon
- 3
No depolarisation
the membrane is not depolarised to threshold
- 4
No action potentials
pain impulses do not reach the brain
Where does lidocaine act: at the synapse or along the axon?
L-DOPA and Parkinson's disease
Dopamine-secreting neurones die in Parkinson's disease; L-DOPA crosses the blood-brain barrier and is converted to dopamine.
In Parkinson's disease dopamine-secreting neurones degenerate, so less dopamine is released at synapses controlling movement, causing tremor, stiff muscles and slow movement. Dopamine cannot cross the blood-brain barrier, but L-DOPA can and is converted into dopamine in the brain. It treats symptoms only: as more neurones die the drug becomes less effective and the dose may need to rise.
- 1
L-DOPA taken
it crosses the blood-brain barrier
- 2
Converted in the brain
L-DOPA becomes dopamine
- 3
Dopamine released
into synapses and binds to dopamine receptors
- 4
Symptoms reduced
transmission is restored
Why is L-DOPA given rather than dopamine itself?
MDMA
MDMA releases serotonin and blocks its reuptake, so it stays longer in the cleft, then leaves stores depleted.
MDMA acts at synapses that use serotonin, and also affects dopamine. It causes release of serotonin into the cleft and inhibits reuptake into the presynaptic knob, so postsynaptic neurones are stimulated more, giving raised mood and euphoria. Afterwards the serotonin stores are depleted, so stimulation falls below normal. This can cause low mood and, with regular use, long-term damage to neurones.
During use
- Serotonin released into the cleft
- Reuptake inhibited
- More postsynaptic stimulation, euphoria
Afterwards
- Presynaptic stores depleted
- Less serotonin released
- Stimulation below normal, low mood
Give two ways MDMA increases the amount of serotonin in the synaptic cleft.
Try an exam question
Explain how alpha toxin from cobra venom can cause death, and why nicotine has a different effect on the same synapses.
[5 marks]
- [1]Alpha toxin binds to acetylcholine receptors at neuromuscular junctions.
- [1]It blocks them, so ACh cannot bind and sodium ion channels stay closed.
- [1]The muscle is not depolarised, so muscles including the diaphragm and intercostals are paralysed, causing respiratory failure.
- [1]Nicotine also binds to the ACh receptors but opens the sodium ion channels, depolarising the membrane.
- [1]It is not broken down by acetylcholinesterase, so the stimulation is prolonged.
That's the notes covered.
Carry on to the next subtopic.
Try a question
What is the target of lidocaine in the sensory neurones?
1 mark, marked against the mark scheme
What is the target of lidocaine in the sensory neurones?
1 mark, marked against the mark scheme